Health & BioTech Companies – Page 2

Itamar Medical, now marketed as ZOLL Itamar, develops WatchPAT home sleep apnea tests and the CloudPAT digital workflow around peripheral arterial tonometry, oximetry, actigraphy, and related physiologic signals. It is an acquired medtech asset within ZOLL Medical, not an independent venture-backed startup.

Carbon Technologies & Solutions (CTS) is an Israeli climate-resilience startup building a repeatable industrial supply platform that converts agricultural and municipal biomass residues into stable biochar for durable carbon removal, then documents deployment through its FieldMRV evidence layer. Its first stated deployment corridor is Israeli agriculture, with a Phase I plan centered on Granot orchards and a current $1.6 million financing ask.

Lembas is an Israeli food-biotechnology startup using AI-guided peptide discovery and licensed university research to develop food-grade bioactive ingredients that support the body's natural GLP-1 response. Its first product, GLP-1 Edge, is positioned as a B2B ingredient for functional foods, beverages, and supplements rather than as a pharmaceutical GLP-1 agonist.

MarineXcell is an Israeli cultivated-seafood startup developing a stem-cell-based process intended to produce genuine shrimp, lobster, and crab meat without fishing or conventional aquaculture. Its strategic thesis is that a scalable, reliable shellfish supply can reduce pressure on marine ecosystems while improving food-system resilience.

Israeli startup developing acoustic-emission sensing systems and cloud AI for continuous structural-health monitoring, predictive maintenance, and early fault detection in industrial assets, infrastructure, vehicles, and aerospace structures.

ForeseeD is an Israeli agritech and food-security startup developing a compact bioconvergence platform for livestock reproduction. Its disclosed technology combines reproductive biology, microfluidics, microscopy, optical image processing, and AI to improve cattle-breeding decisions while aiming to increase food production and animal welfare.

SeaNovel Bioplastic is an Israeli materials startup developing industrial-scale biodegradable resin pellets from Ulva seaweed polysaccharides. Its drop-in thermoplastic is designed for food packaging and single-use products, with the strategic proposition of replacing some fossil-based plastic without requiring manufacturers to replace existing production lines.

Israeli-founded deep-tech medtech company building a computational-ultrasound system (flagship Vortex360) that adapts Full Waveform Inversion — a geophysics/seismic-imaging technique — to reconstruct operator-independent, high-resolution 3D volumetric images at the point of care.

Israeli environmental-biotechnology startup developing the Small Bioreactor Platform (SBP), a semi-permeable capsule system that confines selected microbial cultures while allowing dissolved contaminants and nutrients to diffuse through for targeted water and wastewater bioaugmentation.

Virobix is an Israeli 2026 deep-tech biotech developing a modular targeted viral RNA-delivery platform for solid-tumor cancer therapy. Its approach combines an unmodified, self-amplifying VSV backbone with a swappable tumor-binding engager so potent payloads can be delivered systemically while concentrating activity on malignant cells.

Public Israeli computational chemistry and biology company developing AI-driven small-molecule discovery tools for pharmaceutical and agricultural products, with a focused 2026 strategy centered on its ChemPass AI platform.

Mealiways Technologies is a Haifa-based Israeli food-biotechnology startup developing cultivated fish and other animal-protein products from cells. Its strategic relevance is food-system resilience: a scaffold-free, bioreactor-compatible production route could diversify protein supply and reduce dependence on vulnerable fisheries, although the company remains in R&D and has not publicly demonstrated regulatory approval or commercial-scale output.

MSICS Pharma is an Israeli pharmaceutical startup developing naturally sourced, medical-grade psilocybin and the GMP production platform needed to supply clinical research. Its lead product, MSX-06, is being developed for PTSD, treatment-resistant depression, OCD, and other difficult mental-health indications, giving the company a direct resilience relevance while its clinical and regulatory claims remain early.

Maolac is an Israeli food-biotechnology startup developing AI- and proteomics-guided, colostrum-derived biofunctional proteins designed around human biology. Its low-dose ingredients target gut health, immune support, muscle recovery, mobility, and healthy aging, converting an underused dairy byproduct into clinically tested nutrition inputs for supplement and functional-food brands.

Medium Well Technological Solutions is an Israeli food-biotechnology startup developing BioResin, a plant-derived molecular-separation medium that purifies proteins and enzymes at lower cost while converting agricultural and food-processing byproducts into useful ingredients. Its initial markets are precision fermentation, plant-based proteins, cultivated-food processing, and recovery of valuable molecules from side streams.

Privately held Israeli liquid-biopsy company developing and commercializing PCR-based epigenetic tests for non-invasive cancer detection, led by the commercially available Bladder EpiCheck assay and a lung-cancer development pipeline.

Electric Algae is a Haifa, Israel climate-tech startup commercializing a Technion-derived bioelectric system that harvests electrical current from macroalgae while coupling energy generation with seaweed agriculture. Its strategic relevance is primarily distributed energy, food, and water resilience rather than a demonstrated defense product.

Alma Lasers is an Israeli medical-device company whose Alma brand develops and sells laser, light, radiofrequency, plasma, ultrasound, and shockwave systems for medical aesthetics, dermatology, beauty, and selected surgical indications. It is a mature, wholly owned operating subsidiary of Sisram Medical, the Hong Kong-listed medical-aesthetics group majority-owned by Fosun Pharma.

Sight Diagnostics developed compact blood-analysis systems that use automated sample preparation, optical imaging and computer vision to produce rapid hematology results from small blood samples. Its later strategy broadened toward AI analysis of live immune-cell behavior, but public reporting indicates that the company suspended operations and was effectively closed in 2026.

ECOncrete (ECOncrete Tech Ltd) is an Israeli-founded marine construction-technology company whose bio-enhancing concrete admixtures, science-based surface textures, and engineered armor units turn seawalls, breakwaters, ports, and offshore-energy foundations into structurally durable 'living' infrastructure that recruits marine life while hardening critical coastlines.

CardioScale is an Israeli medical-device company whose patented CVRI (Cardio Vascular Reserve Index) turns a non-invasive arm-cuff measurement into an objective, seconds-long read on a patient's hemodynamic state and trajectory, flagging hidden circulatory deterioration before conventional vital signs go abnormal for trauma, hemorrhage, sepsis, and mass-casualty triage.

Outbrain is an open-web advertising technology business whose recommendation, contextual targeting, and predictive optimization products help publishers monetize attention and advertisers acquire customers. Following its 2025 combination with Teads, the Outbrain technology and Direct Response operations continue under the Teads brand.

Lamin BioTex is an early-stage Israeli advanced-materials startup commercializing recombinant lamin-protein fibers as a bio-inspired reinforcement for carbon- and glass-fiber composites, with the stated goal of making laminates markedly tougher and lighter for aerospace, automotive, defense, and sporting-goods applications.

Voyago is a London, Ontario mobility-services operating brand wholly owned by Transdev, providing public transit, paratransit, student transportation, non-emergency medical transportation, and charter services. It is a mature Canadian transport operator and acquired asset, not an independent venture-backed technology startup.